AIDX institutional ownership changes in Q2 2026: 9 institutions opened or added positions, 4 trimmed or exited. AIDX (20/20 Biolabs, Inc.) is held by 11 institutional investors as of Q2 2026. Top institutional shareholders: Cresset Asset Management, LLC ($131,995), HRT Financial LP ($49,000), Vanguard Fiduciary Trust Co. ($28,648). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Feb 23, 2026 · Activists Mar 10, 2026 · Congress none
Top Holders
Continue exploring
Questions investors ask about AIDX
Who owns AIDX?
11 institutional investors held AIDX on June 30, 2026, led by Cresset Asset Management, LLC ($131,995), HRT Financial LP ($49,000) and Vanguard Fiduciary Trust Co. ($28,648).
How many hedge funds hold AIDX?
11 institutional investors reported AIDX in their 13F filings for the quarter ended June 30, 2026, $275,811 in all. 2 of them are rated Elite.
Are institutions buying or selling AIDX?
Buying, on balance. In Q2 2026, 9 institutions opened or added to positions in AIDX and 4 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer
